PFS Investments’s AstraZeneca AZN Stock Holding History

PFS Investments’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$5.38M	Buy	37,565 +5,784	+18%	+$851K	0.09%	215
2023 Q1	$4.6M	Buy	31,781 +16,377	+106%	+$2.2M	0.08%	211
2022 Q4	$2.09M	Buy	+15,404	New	+$1.93M	0.04%	286

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PFS Investments's AZN Position: Q2 2023 in Review

PFS Investments increased its AstraZeneca (AZN) stake by 18% in Q2 2023, buying an estimated $851K and bringing the position to 37,565 shares worth $5.38M. The position accounts for 0.09% of the portfolio, ranked #215.

PFS Investments first reported a position in AZN in Q4 2022 and has held it in 3 quarters since. 1,090 funds tracked by Wall St. Rank hold AZN as of Q2 2023.

PFS Investments held 37,565 shares of AstraZeneca worth $5.38M as of Q2 2023.
PFS Investments bought 5,784 AstraZeneca shares in Q2 2023, an estimated $851K.
AstraZeneca made up 0.09% of PFS Investments's portfolio in Q2 2023, its #215 holding.
PFS Investments first reported a position in AstraZeneca in Q4 2022 and has held it in 3 quarters since.
1,090 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2023.

Based on PFS Investments's 13F filing for Q2 2023, filed 14 Aug 2023.